BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 2526848)

  • 1. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.
    Munn DH; Cheung NK
    J Exp Med; 1989 Aug; 170(2):511-26. PubMed ID: 2526848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity.
    Young DA; Lowe LD; Clark SC
    J Immunol; 1990 Jul; 145(2):607-15. PubMed ID: 2142182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.
    Baldwin GC; Chung GY; Kaslander C; Esmail T; Reisfeld RA; Golde DW
    Br J Haematol; 1993 Apr; 83(4):545-53. PubMed ID: 7686031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity.
    Liesveld JL; Frediani KE; Winslow JM; Duerst RE; Abboud CN
    J Cell Biochem; 1991 Apr; 45(4):381-90. PubMed ID: 1675219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level.
    Connor RI; Shen L; Fanger MW
    J Immunol; 1990 Sep; 145(5):1483-9. PubMed ID: 1696598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells.
    Qi CF; Nieroda C; De Filippi R; Greiner JW; Correale P; Schlom J; Tsang KY
    Immunol Lett; 1995; 47(1-2):15-24. PubMed ID: 8537095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.
    Munn DH; Garnick MB; Cheung NK
    Blood; 1990 May; 75(10):2042-8. PubMed ID: 2186820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.
    Kushner BH; Cheung NK
    Blood; 1989 May; 73(7):1936-41. PubMed ID: 2653466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity.
    Mufson RA; Aghajanian J; Wong G; Woodhouse C; Morgan AC
    Cell Immunol; 1989 Mar; 119(1):182-92. PubMed ID: 2646026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor.
    Suzu S; Yanai N; Saito M; Kawashima T; Kasahara T; Saito M; Takaku F; Motoyoshi K
    Jpn J Cancer Res; 1990 Jan; 81(1):79-84. PubMed ID: 2108950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.
    Munn DH; Cheung NK
    J Exp Med; 1990 Jul; 172(1):231-7. PubMed ID: 2193096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.
    Metelitsa LS; Gillies SD; Super M; Shimada H; Reynolds CP; Seeger RC
    Blood; 2002 Jun; 99(11):4166-73. PubMed ID: 12010822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of macrophage antibody-dependent killing of tumor targets by recombinant lymphokine factors and M-CSF.
    Nakoinz I; Ralph P
    Cell Immunol; 1988 Oct; 116(2):331-40. PubMed ID: 2460249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human macrophage colony-stimulating factor in nonhuman primates: selective expansion of a CD16+ monocyte subset with phenotypic similarity to primate natural killer cells.
    Munn DH; Bree AG; Beall AC; Kaviani MD; Sabio H; Schaub RG; Alpaugh RK; Weiner LM; Goldman SJ
    Blood; 1996 Aug; 88(4):1215-24. PubMed ID: 8695839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
    Munn DH; Armstrong E
    Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma.
    Minasian LM; Yao TJ; Steffens TA; Scheinberg DA; Williams L; Riedel E; Houghton AN; Chapman PB
    Cancer; 1995 May; 75(9):2251-7. PubMed ID: 7536122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma.
    Chachoua A; Oratz R; Liebes L; Alter RS; Felice A; Peace D; Vilcek J; Blum RH
    J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):132-41. PubMed ID: 7804528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor.
    Munn DH; Cheung NK
    Cancer Immunol Immunother; 1995 Jul; 41(1):46-52. PubMed ID: 7641219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
    Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf IG
    Z Gastroenterol; 2000 Aug; 38(8):615-22. PubMed ID: 11031784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
    Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
    Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.